Elevance Health 2024 Profits Hit $6 Billion Despite Rising Costs
Elevance Health reported nearly $6 billion in 2024 profits including $418 million in the fourth quarter as the health insurer worked to overcome rising medical expenses.
Elevance Health Buy Rating: Growth Potential Despite Cost Challenges
TD Cowen analyst Ryan Langston has maintained their bullish stance on ELV stock, giving a Buy rating on January 24.Invest with Confidence:
Elevance Health expects to grow MA membership by at least 7% in 2025
Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's expectations despite decreasing 51% year-over-year. | Elevance Health posted $418 million in profit for the fourth quarter of 2024,
Elevance Health expects high Medicaid costs to drop in 2025
Medicaid managed care organizations, including Elevance Health, Centene and UnitedHealth Group, are working with states to secure rates that account for sicker patients.
Elevance beats profit estimates on lower-than-expected medical costs
(Reuters) -Elevance Health on Thursday posted quarterly profit slightly above Wall Street expectations, helped by lower-than-expected spending on medical care for its members. The results lifted Elevance's shares more than 5% before the bell and also boosted peers such as Cigna and CVS Health.
Elevance sends Medicaid insurers higher after Q4 revenue beat
Centene (CNC) and Molina Healthcare (MOH) were among the notable gainers in the premarket on Thursday after their rival in the Medicaid space, Elevance Health (NYSE:ELV), reported better-than-expected revenue for Q4 2024.
Elevance Health Stock Rises as Company Tops Estimates, Raises Dividend
Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, ...
Elevance Health Q4 2024 Earnings: Managed Care Continues To Impress
Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...
Elevance Health Inc. (NYSE:ELV) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, ...
Elevance Health (ELV) Initiated with a Buy at Cantor Fitzgerald
Elevance Health (ELV – Research Report) received a Buy rating and a $485.00 price target from Cantor Fitzgerald analyst Sarah James yesterday.
Ibj.com3d
UPDATE: Elevance Health shares tick up on better-than-expected earnings
Elevance Health released fourth-quarter earnings that topped analyst expectations, sending its stock higher in pre-market ...
Managed Care Insurers Get Wall Street Bump Even With Mixed Q4 2024 Results
After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...
Elevance Stock Gains After Strong Quarter. A Dividend Hike Is Another Positive.
Shares of Elevance Health were gaining after the health insurer turned in a strong quarter and increased its quarterly ...
Elevance Health (ELV) Q4 2024 Earnings Call Transcript
Elevance Health (NYSE: ELV) Q4 2024 Earnings Call Jan 23, 2025, 8:30 a.m. ET ...
Elevance Health earnings boost health-insurance stocks after upbeat outlook
Elevance Health Inc.’s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns ...